NCT00862810View on ClinicalTrials.gov

Alternate Dosing Schedules Study for HPV Vaccine

PHASE4CompletedINTERVENTIONAL

Enrollment

72

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions

Cervical CancerGenital Warts

Interventions

BIOLOGICAL

Received HPV vaccine first

BIOLOGICAL

Received concomitant vaccines first

Trial Locations (3)

27514

Chapel Hill Pediatrics, Chapel Hill

27704

Duke Children's Primary Care, Durham

Durham Pediatrics, Durham

Sponsors

Lead Sponsor

Duke University

All Listed Sponsors

collaborator

Centers for Disease Control and Prevention

FED

lead

Duke University

OTHER

NCT00862810 - Alternate Dosing Schedules Study for HPV Vaccine | Biotech Hunter | Biotech Hunter